{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:07:02Z","timestamp":1792598822045,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09949-w","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T07:02:05Z","timestamp":1727506925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Decoding the genetic influence of CT60 non-coding polymorphism in CTLA-4 gene and sCTLA-4 biomarker with rheumatoid arthritis in the Indian population"],"prefix":"10.1007","volume":"51","author":[{"given":"V.","family":"Shamala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-5162","authenticated-orcid":false,"given":"S.","family":"Asha Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"9949_CR1","doi-asserted-by":"publisher","first-page":"201037","DOI":"10.1016\/j.humgen.2022.201037","volume":"33","author":"KS Zayed","year":"2022","unstructured":"Zayed KS, Kudhair BK, Lafta IJ (2022) Association of CTLA-4 (+\u200949A\/G) polymorphism and susceptibility of developing rheumatoid arthritis in an Iraqi arab population. Hum Gene 33:201037. https:\/\/doi.org\/10.1016\/j.humgen.2022.201037","journal-title":"Hum Gene"},{"key":"9949_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0239426","volume":"15","author":"MM Aslam","year":"2020","unstructured":"Aslam MM, Jalil F, John P et al (2020) A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases. PLoS ONE 15:1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0239426","journal-title":"PLoS ONE"},{"key":"9949_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40744-020-00217-4","volume":"7","author":"MN Lwin","year":"2020","unstructured":"Lwin MN, Serhal L, Holroyd C, Edwards CJ (2020) Rheumatoid arthritis: the impact of mental health on disease: a narrative review. Rheumatol Ther 7:457\u2013471. https:\/\/doi.org\/10.1007\/s40744-020-00217-4","journal-title":"Rheumatol Ther"},{"key":"9949_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1123832","volume":"14","author":"DP Chen","year":"2023","unstructured":"Chen DP, Wen YH, Lin WT et al (2023) Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis. Front Immunol 14:1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2023.1123832","journal-title":"Front Immunol"},{"key":"9949_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.598076","volume":"8","author":"W Liu","year":"2021","unstructured":"Liu W, Yang Z, Chen Y et al (2021) The Association between CTLA-4, CD80\/86, and CD28 gene polymorphisms and rheumatoid arthritis: an original study and Meta-analysis. Front Med 8:1\u201310. https:\/\/doi.org\/10.3389\/fmed.2021.598076","journal-title":"Front Med"},{"key":"9949_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jrms.jrms_567_20","volume":"26","author":"MJ Mousavi","year":"2021","unstructured":"Mousavi MJ, Shayesteh MRH, Jamalzehi S et al (2021) Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: a systematic review and meta\u2013analysis. J Res Med Sci 26:1\u201310. https:\/\/doi.org\/10.4103\/jrms.jrms_567_20","journal-title":"J Res Med Sci"},{"key":"9949_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.55133\/eji.300318","volume":"30","author":"D Ragab","year":"2023","unstructured":"Ragab D, Hammoda RM, EL-Gharbawy N, Salem R (2023) Evaluation of CTLA-4 (+\u200949A\/G) polymorphism association with rheumatoid arthritis in Egyptian patients. Egypt J Immunol 30:180\u2013189. https:\/\/doi.org\/https:\/\/pubmed.ncbi.nlm.nih.gov\/37440667\/","journal-title":"Egypt J Immunol"},{"key":"9949_CR8","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y","volume":"29","author":"G Magistrelli","year":"1999","unstructured":"Magistrelli G, Jeannin P, Herbault N et al (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 29:3596\u20133602.","journal-title":"Eur J Immunol"},{"key":"9949_CR9","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.164.10.5015","volume":"164","author":"MK Oaks","year":"2000","unstructured":"Oaks MK, Hallett KM (2000) Cutting edge: a Soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015\u20135018. https:\/\/doi.org\/10.4049\/jimmunol.164.10.5015","journal-title":"J Immunol"},{"key":"9949_CR10","doi-asserted-by":"publisher","first-page":"103995","DOI":"10.1016\/j.cellimm.2019.103995","volume":"347","author":"F Shehjar","year":"2020","unstructured":"Shehjar F, Dil-Afroze, Misgar RA et al (2020) A significant association of the CTLA4 gene variants with the risk of autoimmune Graves\u2019 disease in ethnic Kashmiri population. Cell Immunol 347:103995. https:\/\/doi.org\/10.1016\/j.cellimm.2019.103995","journal-title":"Cell Immunol"},{"key":"9949_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/br.2015.493","volume":"3","author":"W Fang","year":"2015","unstructured":"Fang W, Zhang Z, Zhang J et al (2015) Association of the CTLA4 gene CT60\/rs3087243 single-nucleotide polymorphisms with Graves\u2019 disease. Biomed Rep 3:691\u2013696. https:\/\/doi.org\/10.3892\/br.2015.493","journal-title":"Biomed Rep"},{"key":"9949_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1089\/dna.2010.1021","volume":"29","author":"K Repnik","year":"2010","unstructured":"Repnik K, Potocnik U (2010) CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms. DNA Cell Biol 29:603\u2013610. https:\/\/doi.org\/10.1089\/dna.2010.1021","journal-title":"DNA Cell Biol"},{"key":"9949_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149441","volume":"11","author":"H Patel","year":"2016","unstructured":"Patel H, Mansuri MS, Singh M et al (2016) Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and thyroglobulin (TG) genetic variants with autoimmune hypothyroidism. PLoS ONE 11:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0149441","journal-title":"PLoS ONE"},{"key":"9949_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215","journal-title":"Nucleic Acids Res"},{"key":"9949_CR15","doi-asserted-by":"publisher","first-page":"146584","DOI":"10.1016\/j.gene.2022.146584","volume":"834","author":"M Shri Preethi","year":"2022","unstructured":"Shri Preethi M, Asha Devi S (2022) An attempt to unravel the association of TAGAP gene SNPs with rheumatoid arthritis in the Indian population using high-resolution melting analysis. Gene 834:146584. https:\/\/doi.org\/10.1016\/j.gene.2022.146584","journal-title":"Gene"},{"key":"9949_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-018-0665-y","volume":"19","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Z, Liu M et al (2018) Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves\u2019 disease in a Chinese Han population. BMC Med Genet 19:1\u20139. https:\/\/doi.org\/10.1186\/s12881-018-0665-y","journal-title":"BMC Med Genet"},{"key":"9949_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"Tivol EA, Borriello F, Schweitzer AN et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541\u2013547. https:\/\/doi.org\/10.1016\/1074-7613(95)90125-6","journal-title":"Immunity"},{"key":"9949_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse P, Penninger JM, Timms E et al (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985\u2013988. https:\/\/doi.org\/10.1126\/science.270.5238.985","journal-title":"Science"},{"key":"9949_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10238-009-0038-0","volume":"9","author":"N Torres-carrillo","year":"2009","unstructured":"Torres-carrillo N, Torres-carrillo NM, Mart\u00ednez-Bonilla GE et al (2009) Plasminogen activator inhibitor-1\u00a0C \/ G polymorphism in relation to plasma levels in rheumatoid arthritis. Clin Exp Med 9:223\u2013228. https:\/\/doi.org\/10.1007\/s10238-009-0038-0","journal-title":"Clin Exp Med"},{"key":"9949_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/08916930500050319","volume":"38","author":"Y Ban","year":"2005","unstructured":"Ban Y, Tozaki T, Taniyama M et al (2005) Association of a CTLA-4 3\u2019 untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38:151\u2013153. https:\/\/doi.org\/10.1080\/08916930500050319","journal-title":"Autoimmunity"},{"key":"9949_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-28423-9","volume":"8","author":"Y Chen","year":"2018","unstructured":"Chen Y, Chen S, Gu Y et al (2018) CTLA-4\u2009+\u200949 G\/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function. Sci Rep 8:1\u20138. https:\/\/doi.org\/10.1038\/s41598-018-28423-9","journal-title":"Sci Rep"},{"key":"9949_CR22","doi-asserted-by":"publisher","first-page":"148819","DOI":"10.1016\/j.gene.2024.148819","volume":"930","author":"V Shamala","year":"2024","unstructured":"Shamala V, Asha Devi S (2024) Deciphering the genetic impact of signal peptide missense CTLA-4 polymorphism with rheumatoid arthritis in the Indian population: a case-control and in silico studies. Gene 930:148819. https:\/\/doi.org\/10.1016\/j.gene.2024.148819","journal-title":"Gene"},{"key":"9949_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cell.2013.12.017","volume":"156","author":"AL Karamyshev","year":"2014","unstructured":"Karamyshev AL, Patrick AE, Karamysheva ZN et al (2014) Inefficient SRP interaction with a nascent chain triggers a mRNA quality control pathway. Cell 156:146\u2013157. https:\/\/doi.org\/10.1016\/j.cell.2013.12.017","journal-title":"Cell"},{"key":"9949_CR24","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/285974","author":"B Farago","year":"2010","unstructured":"Farago B, Kisfali P, Magyari L et al (2010) Cytotoxic T lymphocyte-associated antigen\u2009+\u200949G variant confers risk for anti-CCP- and rheumatoid factor-positive type of rheumatoid arthritis only in combination with CT60 G allele. Autoimmune Dis. https:\/\/doi.org\/10.4061\/2010\/285974","journal-title":"Autoimmune Dis"},{"key":"9949_CR25","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/art.22004","volume":"54","author":"S Downie-Doyle","year":"2006","unstructured":"Downie-Doyle S, Bayat N, Rischmueller M, Lester S (2006) Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 54:2434\u20132440. https:\/\/doi.org\/10.1002\/art.22004","journal-title":"Arthritis Rheum"},{"key":"9949_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm10040220","volume":"10","author":"NM Pete","year":"2020","unstructured":"Pete NM, Montoro MDMM, Ram\u00edrez CP et al (2020) Impact of single-nucleotide polymorphisms of CTLA-4, CD80 and CD86 on the effectiveness of abatacept in patients with rheumatoid arthritis. J Pers Med 10:1\u201317. https:\/\/doi.org\/10.3390\/jpm10040220","journal-title":"J Pers Med"},{"key":"9949_CR27","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/ard.2010.144576","volume":"70","author":"P Danoy","year":"2011","unstructured":"Danoy P, Wei M, Johanna H et al (2011) Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Ann Rheum Dis 70:1793\u20131797. https:\/\/doi.org\/10.1136\/ard.2010.144576","journal-title":"Ann Rheum Dis"},{"key":"9949_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s12013-013-9640-6","volume":"67","author":"N Torres-Carrillo","year":"2013","unstructured":"Torres-Carrillo N, Ontiveros-Mercado H, Torres-Carrillo NM et al (2013) The \u2013\u2009319\u00a0C\/+49G\/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population. Cell Biochem Biophys 67:1217\u20131228. https:\/\/doi.org\/10.1007\/s12013-013-9640-6","journal-title":"Cell Biochem Biophys"},{"key":"9949_CR29","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1136\/ard.2009.121020","volume":"69","author":"D Plant","year":"2010","unstructured":"Plant D, Flynn E, Mbarek H et al (2010) Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 69:1548\u20131553. https:\/\/doi.org\/10.1136\/ard.2009.121020","journal-title":"Ann Rheum Dis"},{"key":"9949_CR30","doi-asserted-by":"publisher","first-page":"19397","DOI":"10.18632\/aging.203349","volume":"13","author":"C Zhou","year":"2021","unstructured":"Zhou C, Gao S, Yuan X et al (2021) Association between CTLA-4 gene polymorphism and risk of rheumatoid arthritis: a meta-analysis. Aging 13:19397\u201319414. https:\/\/doi.org\/10.18632\/aging.203349","journal-title":"Aging"},{"key":"9949_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clim.2007.01.003","volume":"123","author":"D Saverino","year":"2007","unstructured":"Saverino D, Brizzolara R, Simone R et al (2007) Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation. Clin Immunol 123:190\u2013198. https:\/\/doi.org\/10.1016\/j.clim.2007.01.003","journal-title":"Clin Immunol"},{"key":"9949_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.diabres.2008.12.003","volume":"83","author":"S Momin","year":"2009","unstructured":"Momin S, Flores S, Angel BB et al (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 83:289\u2013294. https:\/\/doi.org\/10.1016\/j.diabres.2008.12.003","journal-title":"Diabetes Res Clin Pract"},{"key":"9949_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/rheumatology\/keh303","volume":"43","author":"S Sato","year":"2004","unstructured":"Sato S, Fujimoto M, Hasegawa M et al (2004) Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology 43:1261\u20131266. https:\/\/doi.org\/10.1093\/rheumatology\/keh303","journal-title":"Rheumatology"},{"key":"9949_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0165-5728(02)00228-X","volume":"130","author":"XB Wang","year":"2002","unstructured":"Wang XB, Kakoulidou M, Giscombe R et al (2002) Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol 130:224\u2013232. https:\/\/doi.org\/10.1016\/S0165-5728(02)00228-X","journal-title":"J Neuroimmunol"},{"key":"9949_CR35","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/rheumatology\/keh663","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong CK, Lit LCW, Tam LS et al (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989\u2013994. https:\/\/doi.org\/10.1093\/rheumatology\/keh663","journal-title":"Rheumatology"},{"key":"9949_CR36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/intimm\/dxp069","volume":"21","author":"R Simone","year":"2009","unstructured":"Simone R, Brizzolara R, Chiappori A et al (2009) A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol 21:1037\u20131045. https:\/\/doi.org\/10.1093\/intimm\/dxp069","journal-title":"Int Immunol"},{"key":"9949_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.23188","volume":"34","author":"M Garc\u00eda-Chagoll\u00e1n","year":"2020","unstructured":"Garc\u00eda-Chagoll\u00e1n M, Ledezma-Lozano IY, Hern\u00e1ndez-Bello J et al (2020) Expression patterns of CD28 and CTLA-4 in early, chronic, and untreated rheumatoid arthritis. J Clin Lab Anal 34:1\u20137. https:\/\/doi.org\/10.1002\/jcla.23188","journal-title":"J Clin Lab Anal"},{"key":"9949_CR38","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.2337\/db11-0130","volume":"60","author":"KD Gerold","year":"2011","unstructured":"Gerold KD, Zheng P, Rainbow DB et al (2011) The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 60:1955\u20131963. https:\/\/doi.org\/10.2337\/db11-0130","journal-title":"Diabetes"},{"key":"9949_CR39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JMM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506\u2013511. https:\/\/doi.org\/10.1038\/nature01621","journal-title":"Nature"},{"key":"9949_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1365-2567.2009.03083.x","volume":"128","author":"L Karabon","year":"2009","unstructured":"Karabon L, Kosmaczewska A, Bilinska M et al (2009) The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology 128:787\u2013796. https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03083.x","journal-title":"Immunology"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09949-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09949-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09949-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:26:10Z","timestamp":1738729570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09949-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9949"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09949-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Sri Narayani Hospital and Research Centre, Ethical Committee has approved Ethical Clearance (IEC\/IRB No. 29\/08\/07\/2022) for this research study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Proper informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"1023"}}